Kenneth B. Pomerantz
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 9
- Urology top 5%
- Psychiatry and Mental health top 10%
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 5
-
- Cholesterol and Lipid Metabolism 12
- Lipoproteins and Cardiovascular Health 4
-
- Cancer, Lipids, and Metabolism 8
-
- Peroxisome Proliferator-Activated Receptors 7
-
- Fatty Acid Research and Health 5
-
- Nitric Oxide and Endothelin Effects 4
- Co-authors
- David P. HajjarD P HajjarPaul J. CannonAlan R. TallD J FalconeBabette B. WekslerPeter W. RamwellS J Feinmark
- Journals
- Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesRussiaSouth Korea
In The Last Decade
Kenneth B. Pomerantz
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 90
- Biochemistry 185
- Endocrinology, Diabetes and Metabolism 253
- Urology 79
- Psychiatry and Mental health 178
- Pharmacology 194
Countries citing papers authored by Kenneth B. Pomerantz
This map shows the geographic impact of Kenneth B. Pomerantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth B. Pomerantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth B. Pomerantz more than expected).
Fields of papers citing papers by Kenneth B. Pomerantz
This network shows the impact of papers produced by Kenneth B. Pomerantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth B. Pomerantz. The network helps show where Kenneth B. Pomerantz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenneth B. Pomerantz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 3 | |
| 2 | 2005 | 88 | |
| 3 | 2002 | 108 | |
| 4 | 1997 | 6 | |
| 5 | 1995 | 50 | |
| 6 | 1995 | 23 | |
| 7 | 1995 | 18 | |
| 8 | 1993 | 18 | |
| 9 | 1993 | 25 | |
| 10 | 1992 | 6 | |
| 11 | 1992 | 2 | |
| 12 | 1991 | 5 | |
| 13 | 1990 | 30 | |
| 14 | 1990 | 6 | |
| 15 | 1990 | 9 | |
| 16 | 1989 | 24 | |
| 17 | Cicletanine stimulates cholesteryl ester hydrolase activities and prostacyclin production in arterial smooth muscle cells. | 1989 | 6 |
| 18 | 1987 | 95 | |
| 19 | 1985 | 69 | |
| 20 | 1978 | 48 |
About Kenneth B. Pomerantz
Kenneth B. Pomerantz is a scholar working on Biochemistry, Cancer Research and Biochemistry, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (12 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Cancer, Lipids, and Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Inflammatory mediators and NSAID effects (5 papers), Fatty Acid Research and Health (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Biochemistry (185 citations), Endocrinology, Diabetes and Metabolism (253 citations) and Urology (79 citations). Kenneth B. Pomerantz has collaborated with scholars based in United States, Russia and South Korea. Frequent co-authors include David P. Hajjar, D P Hajjar, Paul J. Cannon, Alan R. Tall, D J Falcone, Babette B. Weksler, Peter W. Ramwell, S J Feinmark, Angela Grant and Harry M. Lander. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.